Belharra Therapeutics

Sanofi (NASDAQ: SNY; EPA: SAN), a major French pharmaceutical company, has formed a collaboration with U.S.-based Belharra Therapeutics, a chemoproteomics company focused on the development of small-molecule cancer drugs targeting high-value, elusive drug targets. As per the agreement, Belharra will utilize its non-covalent chemoproteomics platform to screen for hits against…